AM-2201
|
AM-2201
[1-(5-Fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-methanone |
|
| [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone | |
| Synthetic cannabinoids | |
| Synthetic cannabinoid receptor agonists |
|
| 335161-24-5 | |
|
|
InChI=1S/C24H22FNO/c25-15-6-1-7-16-26-17-22(20-12-4-5-14-23(20)26)24(27)21-13-8-10-18-9-2-3-11-19(18)21/h2-5,8-14,17H,1,6-7,15-16H2
|
|
ALQFAGFPQCBPED-UHFFFAOYSA-N
|
|
|
O=C(c2cn(CCCCCF)c1ccccc12)c4cccc3ccccc34
|
|
| C24H22FNO | |
| 359.436 g/mol | |
| 71/II | |
| 2015 | |
|
This substance is included in Schedule II of the 1971 Convention on Psychotropic Substances. |